Chronic heart failure; iron deficiency
Conditions
Brief summary
The performance of the Six-Minute Walking Test (6MWT), comparing the mean difference from baseline of the distance walked by patients in meters.
Detailed description
Assess in the tree-arms treatment during the study the change in Kansas City Cardiomyopathy Questionnaire(KCCQ) score, NYHA class, echocardiographic parameters (parameters of systolic and diastolic function, parietal thicknesses, and left ventricular diameters), calcium and phosphorus profile (levels of calcium, phosphate and human Fibroblast Growth Factors), incidence of fractures, glomerular filtration rate, surviving days out of hospital, hospitalizations and mortality
Interventions
DRUG-
DRUGDIBASE 100.000 U.I./ml soluzione iniettabile
DRUGFerinject 50 mg ferro/mL dispersione iniettabile/per infusione.
Sponsors
Universita Degli Studi Di Padova
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The performance of the Six-Minute Walking Test (6MWT), comparing the mean difference from baseline of the distance walked by patients in meters. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess in the tree-arms treatment during the study the change in Kansas City Cardiomyopathy Questionnaire(KCCQ) score, NYHA class, echocardiographic parameters (parameters of systolic and diastolic function, parietal thicknesses, and left ventricular diameters), calcium and phosphorus profile (levels of calcium, phosphate and human Fibroblast Growth Factors), incidence of fractures, glomerular filtration rate, surviving days out of hospital, hospitalizations and mortality | — |
Countries
Italy
Outcome results
None listed